GENomE wide analysis of sotalol-induced IKr inhibition during ventricular REPOLarization, “GENEREPOL study”: Lack of common variants with large effect sizes

Twenty-eight genetic loci associated with ST-T-wave amplitudes of the electrocardiogram

(2016) Niek Verweij et al.   HUMAN MOLECULAR GENETICS

Complex Influence of Gonadotropins and Sex Steroid Hormones on QT Interval Duration

(2016) Guillaume Abehsira et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Influence of steroid hormones on ventricular repolarization

(2016) Joe-Elie Salem et al.   PHARMACOLOGY & THERAPEUTICS

Rare genetic variants previously associated with congenital forms of long QT syndrome have little or no effect on the QT interval

(2015) Jonas Ghouse et al.   EUROPEAN HEART JOURNAL

Maximizing the Power of Principal-Component Analysis of Correlated Phenotypes in Genome-wide Association Studies

(2014) Hugues Aschard et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Exome Sequencing Implicates an Increased Burden of Rare Potassium Channel Variants in the Risk of Drug-Induced Long QT Interval Syndrome

(2014) Peter Weeke et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization

(2014) Dan E Arking et al.   NATURE GENETICS

QT variability during initial exposure to sotalol: experience based on a large electronic medical record

(2013) Peter Weeke et al.   EUROPACE

Epidemiology of symptomatic drug-induced long QT syndrome and torsade de pointes in Germany

(2013) G. Sarganas et al.   EUROPACE

HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes

(2013) Silvia G. Priori et al.   HEART RHYTHM

Genome Wide Analysis of Drug-Induced Torsades de Pointes: Lack of Common Variants with Large Effect Sizes

(2013) Elijah R. Behr et al.   PLoS One

Drug induced QT prolongation: the measurement and assessment of the QT interval in clinical practice

(2012) Geoffrey K. Isbister et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Drug-induced arrhythmia: pharmacogenomic prescribing?

(2012) E. R. Behr et al.   EUROPEAN HEART JOURNAL

Common Variation in the NOS1AP Gene Is Associated With Drug-Induced QT Prolongation and Ventricular Arrhythmia

(2012) Yalda Jamshidi et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A Large Candidate Gene Survey Identifies the KCNE1 D85N Polymorphism as a Possible Modulator of Drug-Induced Torsades de Pointes

(2011) Stefan Kääb et al.   Circulation-Cardiovascular Genetics

T-wave morphology abnormalities in benign, potent, and arrhythmogenic Ikr inhibition

(2011) Jean-Philippe Couderc et al.   HEART RHYTHM

Quantification of Restitution Dispersion From the Dynamic Changes of the $T$-Wave Peak to End, Measured at the Surface ECG

(2011) A Mincholé et al.   IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING

MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes

(2010) Yun Li et al.   GENETIC EPIDEMIOLOGY

Drug-Induced Long QT Syndrome

(2010) P. Kannankeril et al.   PHARMACOLOGICAL REVIEWS

Identifying Drug-Induced Repolarization Abnormalities from Distinct ECG Patterns in Congenital Long QT Syndrome

(2009) Claus Graff et al.   DRUG SAFETY

Cellular basis of drug-induced torsades de pointes

(2008) D M Roden   BRITISH JOURNAL OF PHARMACOLOGY

Repolarization Reserve

(2008) Dan M. Roden   CIRCULATION

Accurate electrocardiographic assessment of the QT interval: Teach the tangent

(2008) Pieter G. Postema et al.   HEART RHYTHM